Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1964 2
1974 1
1975 2
1976 1
1977 2
1978 4
1980 4
1981 9
1982 5
1983 6
1984 1
1985 5
1986 7
1987 4
1988 5
1989 1
1990 4
1991 4
1992 3
1993 4
1994 6
1995 3
1996 10
1997 6
1998 3
1999 7
2000 11
2001 13
2002 9
2003 13
2004 15
2005 18
2006 14
2007 18
2008 30
2009 20
2010 23
2011 30
2012 28
2013 32
2014 49
2015 38
2016 40
2017 47
2018 37
2019 43
2020 40
2021 43
2022 43
2023 42
2024 42
2025 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

793 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Lo GH, Driban JB. Lo GH, et al. Arthritis Rheumatol. 2025 Feb;77(2):239-240. doi: 10.1002/art.42994. Epub 2024 Oct 7. Arthritis Rheumatol. 2025. PMID: 39300598 No abstract available.
Reply.
Lo GH, Driban JB. Lo GH, et al. Arthritis Rheumatol. 2023 Apr;75(4):643-644. doi: 10.1002/art.42309. Epub 2023 Jan 19. Arthritis Rheumatol. 2023. PMID: 35849799 No abstract available.
Reply.
Lo GH, Driban JB. Lo GH, et al. Arthritis Rheumatol. 2023 Sep;75(9):1684. doi: 10.1002/art.42501. Epub 2023 Jul 19. Arthritis Rheumatol. 2023. PMID: 36924110 No abstract available.
Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management.
Shukla A, Rockey DC, Kamath PS, Kleiner DE, Singh A, Vaidya A, Koshy A, Goel A, Dökmeci AK, Meena B, Philips CA, Sharma CB, Payawal DA, Kim DJ, Lo GH, Han G, Qureshi H, Wanless IR, Jia J, Sollano JD, Al Mahtab M, Muthiah MD, Sonderup MW, Nahum MS, Merican MIB, Ormeci N, Kawada N, Reddy R, Dhiman RK, Gani R, Hameed SS, Harindranath S, Jafri W, Qi X, Chawla YK, Furuichi Y, Zheng MH, Sarin SK. Shukla A, et al. Among authors: lo gh. Hepatol Int. 2024 Dec;18(6):1684-1711. doi: 10.1007/s12072-024-10739-6. Epub 2024 Nov 15. Hepatol Int. 2024. PMID: 39546143
Reply.
Lo GH, Driban JB. Lo GH, et al. Arthritis Care Res (Hoboken). 2018 Jun;70(6):957. doi: 10.1002/acr.23289. Epub 2018 Apr 20. Arthritis Care Res (Hoboken). 2018. PMID: 28544817 Free PMC article. No abstract available.
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial.
Aix SP, Ciuleanu TE, Navarro A, Cousin S, Bonanno L, Smit EF, Chiappori A, Olmedo ME, Horvath I, Grohé C, Farago AF, López-Vilariño JA, Cullell-Young M, Nieto A, Vasco N, Gómez J, Kahatt C, Zeaiter A, Carcereny E, Roubec J, Syrigos K, Lo G, Barneto I, Pope A, Sánchez A, Kattan J, Zarogoulidis K, Waller CF, Bischoff H, Juan-Vidal O, Reinmuth N, Dómine M, Paz-Ares L. Aix SP, et al. Among authors: lo g. Lancet Respir Med. 2023 Jan;11(1):74-86. doi: 10.1016/S2213-2600(22)00309-5. Epub 2022 Oct 14. Lancet Respir Med. 2023. PMID: 36252599 Clinical Trial.
Drs. Lo and Driban reply.
Lo GH, Driban JB. Lo GH, et al. J Rheumatol. 2025 Feb 1;52(2):198-199. doi: 10.3899/jrheum.2024-1166. J Rheumatol. 2025. PMID: 39681378 Free article. No abstract available.
793 results